Rebeccatech LLC(Rebeccatech), a California based medtech company recently announced their Series A+ with Hillhouse Captial, Clearwater Bay Ventures and Pechoin Fund. This multi-million dollar round assisted the transition into a global structure with GMP facilities, clinical trial centers and market deployment around the Pacific rim. A series of disruptive healthcare products have been launched since the signing of A+ round, June 2021.

Rebeccatech focuses on delivering innovative medical solutions to the hands of caregivers and patients. Founded in 2015, the team consists of medical professionals, MEMS scientists and biomedical engineers who specialized in miniaturized physical-factor treatment. It is headquartered in Irvine, an ocean-side, southern California city endowed with top research universities and hospitals. The company's patented MEMS technology aims at bringing a better and healthier life to people.
SOURCE Rebeccatech

Rebeccatech Closes Series A+ On Microrf Technology

Rebeccatech Closes Series A+ On Microrf Technology

Company Info